OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.110
0.00 (0.00%)
Jul 14, 2026, 9:33 AM EDT - Market open
OmniAb Employees
OmniAb had 89 employees as of December 31, 2025. The number of employees decreased by 25 or -21.93% compared to the previous year.
Employees
89
Change (1Y)
-25
Growth (1Y)
-21.93%
Revenue / Employee
$325,157
Profits / Employee
-$609,955
Market Cap
305.89M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 89 | -25 | -21.93% |
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Sep 30, 2022 | 93 | 23 | 32.86% |
| Jun 30, 2022 | 87 | 17 | 24.29% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Sep 30, 2021 | 70 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Lyell Immunopharma | 161 |
| Fate Therapeutics | 161 |
| Zentalis Pharmaceuticals | 106 |
| Foghorn Therapeutics | 106 |
| Neumora Therapeutics | 92 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 55 |
OABI News
- 1 day ago - OmniAb names Nwachuku as Chief Operating Officer - TheFly
- 1 day ago - OmniAb Names Amechi Nwachuku Chief Operating Officer - Business Wire
- 2 months ago - OmniAb reports Q1 EPS (6c), consensus (10c) - TheFly
- 2 months ago - OmniAb raises FY26 revenue view to $28M-$33M, consensus $28.0M - TheFly
- 2 months ago - OmniAb Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - OmniAb Slides: Q1 2026 - Filings
- 2 months ago - OmniAb Earnings release: Q1 2026 - Filings
- 2 months ago - OmniAb Quarterly report: Q1 2026 - Filings